Implementation of Uniform Food and Drug Administration Refusal Notification Process for all Post Release Refusals Effective October 1, 2022
Published Sep 28, 2022
Summary
CBP and FDA are implementing a uniform, nationwide notification process effective October 1, 2022 for post-release FDA refusals, under which CBP's Centers of Excellence and Expertise will issue the CBP Form 4647 Demand for Redelivery via the ACE forms module after FDA issues a refusal notice.
Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.
CSMS 53438144 · full bulletinRelated bulletins
ACE Certification Standard Invasive Maintenance Window from 5:00 p.m. ET to 8:00 p.m. ET
Jul 28, 2026
New e214 Error Code Validation for Post Admission Corrections and Updated Appendix P
Jul 28, 2026
Consumer Product Safety Commission (CPSC) Implementation Guide and Partner Government Agency (PGA) Flag Enforcement Table Documents Updated on CBP.gov
Jul 28, 2026
Harmonized System Update (HSU) 2617
Jul 27, 2026
Harmonized System Update (HSU) 2616
Jul 23, 2026